At the time of the occurrence of DLBCL, VAF of the TP53 mutation increased in parallel with that of the DNMT3A and TET2 mutations; cytogenetic analysis showed additional abnormalities including, deletion 5q and trisomy 8. This evidence concerns the gene DNMT3A and diffuse large B-cell lymphoma.